The effect of myocardial injury on the clinical course of snake envenomation in South Korea

References

• Karaye KM, Mijinyawa MS, Yakasai AM, et al. Cardiac and hemodynamic features following snakebite in Nigeria. Int J Cardiol. 2012;156(3):326–328.
   PubMed Web of Science ®Google Scholar
• Gutiérrez JM, Lomonte B, León G, et al. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics. 2009;72(2):165–182.
   PubMed Web of Science ®Google Scholar
• Dehghani R, Mehrpour O, Shahi MP, et al. Epidemiology of venomous and semi-venomous snakebites (Ophidia: Viperidae, Colubridae) in the Kashan city of the Isfahan province in Central Iran. J Res Med Sci. 2014;19(1):33–40.
   PubMed Web of Science ®Google Scholar
• Kim OH, Lee JW, Kim HI, et al. Adverse cardiovascular events after a venomous snakebite in Korea. Yonsei Med J. 2016;57(2):512–751.
   PubMed Web of Science ®Google Scholar
• Rha JH, Kwon SM, Oh JR, et al. Snakebite in Korea: a guideline to primary surgical management. Yonsei Med J. 2015;56(5):1443–1448.
   PubMed Web of Science ®Google Scholar
• Silva de Oliveira S, Freitas-de-Sousa LA, Alves EC, et al. Fatal stroke after Bothrops snakebite in the Amazonas state, Brazil: a case report. Toxicon. 2017; Nov138:102–106.
   PubMed Web of Science ®Google Scholar
• Berling I, Brown SG, Miteff F, et al. Intracranial haemorrhages associated with venom induced consumption coagulopathy in Australian snakebites (ASP-21). Toxicon. 2015;102:8–13.
   PubMed Web of Science ®Google Scholar
• Slagboom J, Kool J, Harrison RA, et al. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise. Br J Haematol. 2017;177(6):947–959.
   PubMed Web of Science ®Google Scholar
• Nayak KC, Jain AK, Sharda DP, et al. Profile of cardiac complications of snake bite. Indian Heart J. 1990;42(3):185–188.
   PubMedGoogle Scholar
• John Binu A, Kumar Mishra A, Gunasekaran K, et al. Cardiovascular manifestations and patient outcomes following snake envenomation: a pilot study. Trop Doct. 2019;49(1):10–13.
   PubMed Web of Science ®Google Scholar
• Habib AG, Abubakar SB. Factors affecting snakebite mortality in north-eastern Nigeria. Int Health. 2011;3(1):50–55. Mar
   PubMed Web of Science ®Google Scholar
• Kariyanna PT, Jayarangaiah A, Kamran H, et al. Myocardial Infarction after Snakebite Envenomation: a Scoping Study. Scifed J Cardiol. 2018;2(3):21.
   Google Scholar
• Gutiérrez JM, Calvete JJ, Habib AG, et al. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063.
   PubMed Web of Science ®Google Scholar
• Gerardo CJ, Vissoci JRN, Evans CS, et al. Does this patient have a severe snake envenomation?: the rational clinical examination systematic review. JAMA Surg. 2019;154(4):346–354.
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Kim JW, Park S, et al. Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study. Acute Crit Care. 2019;34(4):269–275.
   PubMed Web of Science ®Google Scholar
• Jun DH, Lee DP, Choi WI. Initial assessment of the snake bites with local effects. J Korean Soc Emergency Med. 2004;15:523–530.
   Google Scholar
• Lee BJ, Hong SI, Kim HS, et al. Hematological features of coagulopathy and the efficacy of antivenin theapy for a Korean Snakebites. Ann Surg Treat Res. 2007;72:18–28.
   Google Scholar
• Cha YS, Lee KY, Lee SJ, et al. Usefulness of delta neutrophil index for early prediction of overt disseminated intravascular coagulopathy in patients with venomous snakebite. Clin Exp Emerg Med. 2018;5(2):76–83.
   PubMed Web of Science ®Google Scholar
• Han SK, Kim IS, Ryu S, et al. The effectiveness of antivenom in treating snake bites resulting in minimal clinical symptoms. J Korean Soc Emerg Med. 2007;18:577–583.
   Google Scholar
• You KM, Kwon WY, Kwon TH, et al. Optimal dose of antivenin for asymptomatic or minor envenomation patient with Korean Viperidae injuries. J Korean Soc Emerg Med. 2013;24:420–427.
   Google Scholar
• Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–376.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Maduwage K, Scorgie FE, et al. Venom concentrations and clotting factor levels in a prospective cohort of russell's viper bites with coagulopathy. PLoS Negl Trop Dis. 2015;9(8):e0003968.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Scorgie FE, O'Leary MA, ASP Investigators, et al. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost. 2010;8(11):2504–2513.
   PubMed Web of Science ®Google Scholar
• Berling I, Isbister GK. Hematologic effects and complications of snake envenoming. Transfus Med Rev. 2015;29(2):82–89.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Maekawa T, Takada M, et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;(49):265–275.
   PubMedGoogle Scholar
• Rucavado A, Soto M, Escalante T, et al. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. Thromb Haemost. 2005;94(1):123–131.
   PubMed Web of Science ®Google Scholar
• Boels D, Hamel JF, Le Roux G, et al. Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav® and Viperatab®. Clin Toxicol (Phila). 2020;31:S33.
   Google Scholar
• Gutiérrez JM, León G, Lomonte B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet. 2003;42(8):721–741.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264.
   PubMed Web of Science ®Google Scholar
• Kumar KS, Narayanan S, Udayabhaskaran V, et al. Clinical and epidemiologic profile and predictors of outcome of poisonous snake bites - an analysis of 1,500 cases from a tertiary care center in Malabar, North Kerala, India. Int J Gen Med. 2018; Jun 511:209–216.
   PubMed Web of Science ®Google Scholar
• Pore SM, Ramanand SJ, Patil PT, et al. A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care setting. Indian J Pharmacol. 2015; May-Jun47(3):270–274.
   PubMed Web of Science ®Google Scholar
• Williams HF, Layfield HJ, Vallance T, et al. The urgent need to develop novel strategies for the diagnosis and treatment of snakebites. Toxins (Basel). 2019;11:363.
   Web of Science ®Google Scholar
• Lalloo DG, Trevett AJ, Nwokolo N, et al. Electrocardiographic abnormalities in patients bitten by taipans (Oxyuranus scutellatus canni) and other elapid snakes in Papua New Guinea. Trans R Soc Trop Med Hyg. 1997;91(1):53–56.
   PubMed Web of Science ®Google Scholar
• Karabuva S, Lukšić B, Brizić I, et al. Ammodytin L is the main cardiotoxic component of the Vipera ammodytes ammodytes venom. Toxicon. 2017;139:94–100.
   PubMed Web of Science ®Google Scholar
• Gasanov SE, Dagda RK, Rael ED. Snake venom cytotoxins, phospholipase A2s, and Zn2+-dependent metalloproteinases: mechanisms of action and pharmacological relevance. J Clin Toxicol. 2014;4(1):1000181.
   PubMedGoogle Scholar